A single-blind study comparing acitretin and narrow-band UVB with the combination of placebo and narrow-band UVB in the treatment of plaque-type psoriasis Plak tip psoriasis tedavisinde asitretin ve dar bant UVB ile plasebo ve dar bant UVB kombinasyonunun karşilaştirildiʇi tek kör çalişma
Turkderm Deri Hastaliklari ve Frengi Arsivi, cilt.49, sa.1, ss.2-6, 2015 (Scopus, TRDizin)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 49 Sayı: 1
- Basım Tarihi: 2015
- Doi Numarası: 10.4274/turkderm.54771
- Dergi Adı: Turkderm Deri Hastaliklari ve Frengi Arsivi
- Derginin Tarandığı İndeksler: Scopus, TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.2-6
- Anahtar Kelimeler: Psoriasis, narrow-band UVB, acitretin, Skindex 29
- Sağlık Bilimleri Üniversitesi Adresli: Hayır
Özet
Background and Design: In this study, we aimed to compare the effects of the combination of acitretin and narrow-band UVB with the combination of placebo and narrow-band UVB in the treatment of plaque-type psoriasis. Materials and Methods: A total of 50 patients with plaque-type psoriasis, in whom more than 10% of the body surface area was affected, were divided into 2 groups of 25 subjects. The first group was treated with narrow-band UVB and 25 mg/day oral acitretin and the second group was treated with narrow-band UVB and placebo. The patients were evaluated every 2 weeks during a 12 week-period. In each patient visit, psoriasis area severity index (PASI) scores were evaluated by an independent observer. Self-administered PASI (SAPASI) scores were calculated. Pre- and post-treatment quality of life was evaluated using the Skindex 29. Results: The study included a total of 50 patients (25 female, 25 male) aged 18-71 years. When PASI and SAPASI changes were evaluated, there were significant differences between the two groups at second week (p<0.05). In addition, there were significant differences between the two groups in terms of PASI and SAPASI values at 4th , 6th , 8th , 10th and 12th weeks (p<0.001). Clinical response was found to be better in patients treated with the combination of acitretin and narrow-band UVB compared to those treated with narrow-band UVB therapy alone. Both treatment protocols were found to lead to significant improvement in the scores of the symptoms, function and emotional scales of Skindex 29. Conclusion: Because of short and better response to combination treatment, clinicians may prefer combination treatment for patients who have psoriasis vulgaris and are suitable for taking narrow-band UVB and acitretin. Psoriasis is considered as a kind of disease that has significant impacts on quality of life.